Immunocellular Therapeutics Overview

  • Founded
  • 1987
Founded
  • Status
  • Public
  • Employees
  • 4
Employees
  • Stock Symbol
  • IMUC
Stock Symbol
  • Share Price
  • $0.75
  • (As of Friday Closing)

Immunocellular Therapeutics General Information

Description

ImmunoCellular Therapeutics Ltd is a US-based clinical-stage biotechnology company. It is engaged in developing immune-based therapies for the treatment of cancers which can elicit an immune response against several antigens. The company has developed ICT-107, which is a dendritic cell (DC) immunotherapy for the treatment of newly diagnosed glioblastoma multiforme (GBM), which is a lethal type of brain cancer. It develops Immunotherapies for treating cancer in which a patient's own immune system is stimulated to target tumor antigens, which are molecular signals that the immune system uses to identify foreign bodies.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
PINX
Primary Office
  • 23622 Calabasas Road
  • Suite 300
  • Calabasas, CA 91302
  • United States
+1 (818) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Immunocellular Therapeutics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.75 $0.81 $0.16 - $0.98 31.5K

Immunocellular Therapeutics Financials Summary

In Thousands,
USD
TTM 30-Jun-2018 FY 2017 31-Dec-2017 FY 2016 31-Dec-2016 FY 2015 31-Dec-2015
EV 5,871 5,116 (5,895) 7,652
Revenue 0 0 0 0
EBITDA (5,650) (13,386) (20,723) (12,641)
Net Income (5,664) (14,312) (22,086) (12,791)
Total Assets 3,829 7,009 16,890 30,082
Total Debt 0 0 574 1,959
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Immunocellular Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Immunocellular Therapeutics‘s full profile, request access.

Request a free trial

Immunocellular Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
ImmunoCellular Therapeutics Ltd is a US-based clinical-stage biotechnology company. It is engaged in developing immune-b
Biotechnology
Calabasas, CA
4 As of 2018
00.000
00000000000 00.000

0000000

ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
0000000000000
Summit, NJ
0000 As of 0000
000.00
00.00 0000-00-00
000000&0 000.00

0000 000

ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor i
0000000000000
Santa Monica, CA
000 As of 0000
00000
000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Immunocellular Therapeutics Competitors (32)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Celgene Formerly VC-backed Summit, NJ 0000 000.00 000000&0 000.00
0000 000000 Formerly VC-backed Santa Monica, CA 000 00000 000000&0 00000
0000000000 0000000 Venture Capital-Backed Mont-Saint-Guibert, Belgium 00 00000 00000000000 00000
0000000 0000000000 Corporation San Diego, CA 00 00000 000000000 00000
00000000 000000000 Formerly VC-backed Newtown, PA 00 00000 00000000 00000
You’re viewing 5 of 32 competitors. Get the full list »

Immunocellular Therapeutics Executive Team (6)

Name Title Board Seat Contact Info
Gary Titus Chairman & Board Member
You’re viewing 1 of 6 executive team members. Get the full list »

Immunocellular Therapeutics Board Members (17)

Name Representing Role Since
0000 00000 Immunocellular Therapeutics Chairman & Board Member 000 0000
0000 00 00 Immunocellular Therapeutics Board Member 000 0000
00000 0000000 00.0 Self Board Member 000 0000
You’re viewing 3 of 17 board members. Get the full list »

Immunocellular Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial